YaoPharma Co., Ltd. entered into an equity transfer agreement to acquire Daiichi Sankyo Pharmaceutical (Beijing) Co., Ltd. from Daiichi Sankyo Company, Limited (TSE:4568) on March 31, 2022. For the period ended December 31, 2021, Daiichi Sankyo Pharmaceutical reported revenues of CNY 720 million, Total assets of CNY 1140 million, Net assets of CNY 960 million, and Net income of CNY 230 million. The transfer procedure is projected to be completed by the end of August 2022, following approval of the Chinese regulatory authority.